Showing results (551-560 of 912) with videos related to

Sort By:
Pageof 92
Cardiovascular Intervention and Therapeutics|April 30, 2013
Safety and feasibility of high-dose administration of nicorandil before reperfusion therapy in acute myocardial infarctionYasunori Suematsu, Yoshinobu Murasato, Shin-Ichiro Miura, et al.
Cardiovascular Intervention and Therapeutics|June 12, 2013
Combined intracoronary thrombolysis, thrombus aspiration and mesh-covered stent implantation for organized massive thrombus burden in ectatic coronaryJ A Linares Vicente, A Lukic, J R Ruiz Arroyo, et al.
Cardiovascular Intervention and Therapeutics|October 15, 2013
Enhanced platelet activation following coronary stent implantation in patients on hemodialysisQiang Fu, Shuichi Ishikawa, Naoyuki Yokoyama, et al.
Cardiovascular Intervention and Therapeutics|October 15, 2013
Hyperuricemia as a risk factor for progressive renal insufficiency after coronary intervention in patients with chronic kidney diseaseShinichi Okino, Shigeru Fukuzawa, Masayuki Inagaki, et al.
Cardiovascular Intervention and Therapeutics|October 15, 2013
Successful treatment of spontaneous coronary bypass rupture using a polytetrafluoroethylene-covered stentKatsuro Kashima, Goichi Yotsumoto, Ryuichi Miyajima, et al.
Cardiovascular Intervention and Therapeutics|October 15, 2013
A case of coronary lesion with lotus root appearance treated by percutaneous coronary intervention with intravascular ultrasound guidanceTomoyuki Nakanishi, Masahito Kawata, Takeshi Matsuura, et al.
Cardiovascular Intervention and Therapeutics|October 15, 2013
Impact of chronic kidney disease on clinical and angiographic results following implantation of sirolimus-eluting coronary stentsYota Kawamura, Yoshihiro Morino, Masakazu Nagaoka, et al.
Cardiovascular Intervention and Therapeutics|October 15, 2013
Effect of cilostazol on optimized standard antiplatelet therapy in a patient with a cytochrome P450 2C19 *2/*2 genotypeQiang Fu, Nobuaki Suzuki, Kaoru Takada, et al.
Pageof 92